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protein kinase activities in bovine cytoplasts obtained by chemical enucleation techniques.
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Abstract
Chemical enucleation using microtubule-depolymerizing drugs is an attractive procedure to simplify the enucleation process in
nuclear transfer. The aim of this study was to optimize chemically assisted (CA) and chemically induced (CI) enucleation
protocols using metaphase II (MII) and pre-activated bovine oocytes, respectively, and to evaluate the activity of maturation
promoting factor (MPF) and mitogen-activated protein kinase (MAPK) in cytoplasts generated by these techniques. Initially, we
determined the shortest effective treatment of MII and activated oocytes with 0.05μgmL(-1) demecolcine. Bovine oocytes in
vitro matured (IVM) for 19h (MII) or activated artificially with 5μM ionomycin (5min) and 10μgmL(-1) cycloheximide (5h) after
26h IVM were treated with demecolcine and samples were collected at 0, 0.25, 0.5, 1.0, 1.5, and 2.0h of treatment. Oocytes
were then stained with 10μgmL(-1) Hoechst 33342 and the protrusion or enucleation rates were determined. Next, we
evaluated histone H1 and myelin basic protein (MBP) kinases, reflecting MPF and MAPK activities, respectively, in oocytes
obtained from these treatments, and for that we used the method described by Kubelka et al. (2000 Biol. Reprod. 62,
292-302). Protrusion and enucleation rates were evaluated by the chi-squared (χ(2)) test, and MPF and MAPK activities were
submitted to ANOVA and Tukey's test at 5% significance. For MII oocytes, effects of demecolcine were observed as early as
15min, with a significant difference (P<0.05) between control (12/112, 10.7%) and treated (33/114, 28.9%) groups in relation to
protrusion rates. The largest number of protrusions was observed after 1.0h of treatment (control: 15/113, 13.3%(a); treated:
45/111, 40.5%(b)). In pre-activated oocytes, effects of demecolcine were also observed after 15min, and in both techniques
there were no significant differences between groups treated with demecolcine for 1.0, 1.5, or 2.0h (CA: 40.5 to 52.5% of
protrusion; CI: 35.2 to 46.7% of enucleation). In contrast to previous reports in which high concentrations of demecolcine for
CA enucleation increased MPF activity, we observed no alterations in the activity of this factor at a demecolcine concentration
of 0.05μgmL(-1). Activity of MAPK also did not differ significantly between the control and treated groups throughout
evaluation. In the CI technique, a significant difference in MPF activity was observed after 0.5h (70.3%) and 2.0h of activation
(39.1%), considering that the activity was 100% at the beginning of the evaluation. However, we observed no significant
difference between the control and treated groups at any of the time points studied, as verified for MAPK activity. The exact
effect of MPF on the nucleus in mammals is not well established. We believe that the use of low concentrations of
demecolcine for short periods is less damaging to embryonic development and, until we have a better understanding of the
effect of these kinases on the transferred nucleus, we recommend its use for chemical enucleation protocols in bovine.
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